Spatial heterogeneity in medulloblastoma.

Nat Genet 2017 May 10;49(5):780-788. Epub 2017 Apr 10.

Developmental &Stem Cell Biology Program, The Hospital for Sick Children, Toronto, Ontario, Canada.

Spatial heterogeneity of transcriptional and genetic markers between physically isolated biopsies of a single tumor poses major barriers to the identification of biomarkers and the development of targeted therapies that will be effective against the entire tumor. We analyzed the spatial heterogeneity of multiregional biopsies from 35 patients, using a combination of transcriptomic and genomic profiles. Medulloblastomas (MBs), but not high-grade gliomas (HGGs), demonstrated spatially homogeneous transcriptomes, which allowed for accurate subgrouping of tumors from a single biopsy. Conversely, somatic mutations that affect genes suitable for targeted therapeutics demonstrated high levels of spatial heterogeneity in MB, malignant glioma, and renal cell carcinoma (RCC). Actionable targets found in a single MB biopsy were seldom clonal across the entire tumor, which brings the efficacy of monotherapies against a single target into question. Clinical trials of targeted therapies for MB should first ensure the spatially ubiquitous nature of the target mutation.

Download full-text PDF

Source
http://dx.doi.org/10.1038/ng.3838DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5553617PMC
May 2017
57 Reads
14 Citations
29.352 Impact Factor

Publication Analysis

Top Keywords

spatial heterogeneity
16
targeted therapies
8
entire tumor
8
single biopsy
8
demonstrated spatially
4
hggs demonstrated
4
gliomas hggs
4
transcriptomes allowed
4
spatial
4
clonal entire
4
seldom clonal
4
high-grade gliomas
4
spatially homogeneous
4
homogeneous transcriptomes
4
mbs high-grade
4
glioma renal
4
transcriptomic genomic
4
combination transcriptomic
4
patients combination
4
single target
4

Similar Publications